Skip to content

Abnormal Circulating Gastrin Concentration C5139563

Published: July 22, 2026Updated: August 20, 2026

This involves abnormal gastrin hormone levels, which help regulate stomach acid production. It may indicate stomach or intestinal conditions. Treatment addresses the specific gastrointestinal issue.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
K76.9
ICD-11
DA00.0
Body system
gastrointestinal
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Gastrointestinal bleeding

Bleeding in the digestive tract, often from peptic ulcers, which may appear as blood in vomit or black, tarry stools.

Seek immediate emergency care if you experience vomiting blood, bloody stools, or signs of blood loss such as dizziness or fainting.

!

Severe persistent pain

Intense, unrelenting abdominal pain that may indicate complications such as ulcer perforation or pancreatic involvement.

Seek immediate emergency care for sudden, severe abdominal pain that does not improve.

Recurrent abdominal pain

(gastrointestinal)

Persistent pain in the upper abdomen, often occurring after meals, due to excess stomach acid production irritating the stomach lining.

Frequency: 70-80% of patients

Heartburn and acid reflux

(gastrointestinal)

Burning sensation in the chest and throat caused by stomach acid flowing back into the esophagus due to increased gastric acid secretion.

Frequency: 75-85% of patients

Chronic diarrhea

(gastrointestinal)

Loose, watery stools occurring frequently throughout the day, resulting from excess gastric acid stimulating intestinal motility.

Frequency: 60-70% of patients

Nausea with vomiting

(gastrointestinal)

Feeling of sickness with an urge to vomit, often triggered by stomach acid irritation and delayed gastric emptying.

Frequency: 50-60% of patients

Peptic ulcers

(gastrointestinal)

Open sores in the stomach or duodenal lining caused by excessive acid production eroding the protective mucosal layer.

Frequency: 40-50% of patients

Unintentional weight loss

(constitutional)

Gradual loss of body weight without trying, often due to reduced appetite, malabsorption, and chronic diarrhea associated with high gastrin levels.

Frequency: 35-45% of patients

Bloating and early satiety

(gastrointestinal)

Feeling of fullness and abdominal distension even after eating small amounts, caused by delayed stomach emptying from acid overproduction.

Frequency: 40-50% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

GI disease management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Proton pump inhibitor therapy

Acid-suppression medication to reduce gastric acid production when elevated gastrin is contributing to esophageal or gastric irritation. Long-term use requires evaluation of underlying cause.

medication
3

H. pylori testing and eradication

Testing for Helicobacter pylori infection, which can cause hypergastrinemia, followed by appropriate antibiotic eradication therapy if positive.

procedure

Additional treatment options

Gastric-friendly dietary modifications

Avoidance of known gastric irritants including spicy foods, caffeine, alcohol, and acidic beverages. Emphasis on smaller, more frequent meals and adequate hydration.

dietary

Endoscopy and gastrin monitoring

Upper endoscopy to evaluate gastric mucosa and serial gastrin level measurements to assess treatment response and identify persistent abnormalities.

monitoring

H2 receptor antagonist therapy

Alternative acid-suppression therapy using H2 blockers for patients who do not tolerate proton pump inhibitors or need step-down therapy.

medication

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abnormal Circulating Gastrin Concentration C5139563?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

NCCN Clinical Practice Guidelines in Oncology: Neuroendocrine Tumors. Version 2.2023.

guideline2023View source →
2

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: 2023 Update.

guideline2023View source →
3

Jensen RT, Cadiot G, Brandi ML, et al. ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms: Functional Pancreatic Endocrine Tumor Syndromes.

review2017View source →
4

Strosberg J, Al-Toubah T, Pelle E, et al. Association Between Serum Gastrin and Survival in Patients with Metastatic Midgut Neuroendocrine Tumors.

meta_analysis2021View source →
5

Modlin IM, Oberg K, Chung DC, et al. Gastrointestinal neuroendocrine tumours: current diagnosis and management.

review2010View source →
6

Rindi G, Wiedenmann B. Neuroendocrine neoplasms of the gut and pancreas: consensus recommendations and future perspectives.

consensus2022View source →
7

Kulke MH, Siu LL, Tepper JE, et al. Future Directions in the Treatment of Neuroendocrine Tumors: Consensus Report of the National Cancer Institute Neuroendocrine Tumor Clinical Trials Planning Meeting.

clinical_trial2011View source →
8

Delle Fave G, O'Toole D, Sundin A, et al. ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms.

position_statement2016View source →
9

Foster R, Yao J, Katz M, et al. The Role of Gastrins and Gastrin Analogs in Pancreatic Neuroendocrine Tumors.

review2020View source →
10

UpToDate. Hypergastrinemia: Etiology and clinical manifestations. Updated 2024.

Medication Comparisons

Compare medications used to treat Abnormal Circulating Gastrin Concentration C5139563. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy